Secciones/Liderazgo

Liderazgo

Las personas y decisiones que marcan el rumbo del sector: estrategia, sucesión y las decisiones que definen a las empresas.

EstrategiaDirectivosCulturaFusiones y adquisiciones
Why Pharma Brands Are Choosing Trust Over Traffic in 2026Artículo
Historia principal

Why Pharma Brands Are Choosing Trust Over Traffic in 2026

From TikTok skinny-shot scandals to AI Overviews, pharma branding now hinges on being trusted, not just seen. Here's what's changed.

Vaibhavi M. · 27 jul 2026
Your Research Is Powerful. Is Anyone Listening?
Artículo

Your Research Is Powerful. Is Anyone Listening?

Personal branding and communication skills now drive funding, hiring and career growth for scientists in pharma and biotech.

Vaibhavi M. · 30 jun 2026
De-Risking AI Biotech: How Institutional Investors Value Tech-Bio Platforms
Artículo

De-Risking AI Biotech: How Institutional Investors Value Tech-Bio Platforms

AI biotech platforms can't be valued like traditional pipelines. Here's the checklist, metrics, and methods institutional investors use to price them.

Vaibhavi M. · 27 jun 2026
Market Map: The Venture Capital Firms Dominating AI Drug Discovery Investments
Artículo

Market Map: The Venture Capital Firms Dominating AI Drug Discovery Investments

ARCH, Foresite, Sequoia and a16z lead the venture capital race in AI drug discovery, see the market map and the biggest bets.

Mrudula Kulkarni · 27 jun 2026
Big Pharma’s Appetite For AI: Analyzing Recent M&A Deals In Small Molecule Chemistry
Artículo

Big Pharma’s Appetite For AI: Analyzing Recent M&A Deals In Small Molecule Chemistry

AI in drug discovery is reshaping small molecule chemistry through M&A Recursion, Exscientia, Schrödinger and Insilico lead the wave.

Simantini Singh Deo · 25 jun 2026
High-Value Partnerships: Notable AI Drug Discovery Out-Licensing Deals In Oncology
Artículo

High-Value Partnerships: Notable AI Drug Discovery Out-Licensing Deals In Oncology

AI biotechs are out-licensing oncology assets to big pharma at scale. Here's how the deals work, who's leading, and why it's working.

Simantini Singh Deo · 24 jun 2026
Where Is The Money Going? Tracking Biotech AI Seed Funding In Cancer Research
Artículo

Where Is The Money Going? Tracking Biotech AI Seed Funding In Cancer Research

AI cancer seed funding is surging despite a tighter market. Here's where the money flows, who backs it, and what the bets signal for pharma.

Simantini Singh Deo · 12 jun 2026
A Founder’s Guide To Computational Chemistry Platforms For Early-Stage Oncology Startups
Artículo

A Founder’s Guide To Computational Chemistry Platforms For Early-Stage Oncology Startups

How oncology startups can use computational chemistry platforms to speed up drug discovery, cut costs, and make smarter research decisions

Simantini Singh Deo · 4 jun 2026
FDA Computer Software Assurance (CSA): A Definitive Guide for Pharma Leaders
Artículo

FDA Computer Software Assurance (CSA): A Definitive Guide for Pharma Leaders

FDA Computer Software Assurance explained, CSA vs CSV, six step framework, SaaS validation and implementation roadmap for pharma leaders.

Mrudula Kulkarni · 25 may 2026
How To Prepare For A Remote Audit: A Step-by-Step Guide
Artículo

How To Prepare For A Remote Audit: A Step-by-Step Guide

Remote audit prep: 6-step checklist for coordination, documents, digital tools, team training, equipment and compliance verification.

Simantini Singh Deo · 21 may 2026